Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry, Hospital Groups Debate Implementation Deadlines For UDI Rule

This article was originally published in The Gray Sheet

Executive Summary

Device industry groups are calling for FDA to extend the timeframes for requiring unique device identifiers on all products to allow firms more time to prepare, while hospitals are urging a shorter implementation timetable to enable earlier use of the system to track devices and recalls.


Related Content

Regulatory Briefs: OMB Updates On UDI, eMDR Rule; Circ Panel Scheduled
FDA Reconsiders UDI Direct Marking Requirements For Implants
UDIs And Adverse Events Draw Attention In Electronic Record Meaningful Use Comments
Regulatory News In Brief
Final UDI Rule Date Uncertain, But Firms Should Prep Now, FDA Says
FDA’s UDI Draft Rule Details Device Marking, Database Submission Mandates





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts